Phenotypic alterations in pancreatic lymph node stromal cells from human donors with type 1 diabetes and NOD mice
- 5 September 2019
- journal article
- research article
- Published by Springer Nature in Diabetologia
- Vol. 62 (11) , 2040-2051
Abstract
Aims/hypothesis Tolerance induction in lymph nodes can be mediated by both haematopoietic cells (e.g. specific dendritic cells subsets) and by non-haematopoietic cells (e.g. lymph node stromal cells [LNSCs]) when they present peripheral tissue antigens to autoreactive T cells. LNSCs normally regulate T cell trafficking and survival and help to maintain peripheral tolerance by exerting immunosuppressive effects. However, whether autoimmunity can be associated with defective tolerogenic functions of LNSCs is unknown and studies aimed at characterising LNSCs in humans are lacking. We hypothesised that dysregulated T cell responses in pancreatic lymph nodes (PLNs) from donors with type 1 diabetes and from NOD mice may be associated with altered LNSC function. Methods We analysed PLNs from donors with type 1 diabetes and NOD mice for LNSC distribution and phenotype using flow cytometry. We assessed the expression of tolerance-related genes in different subsets of LNSCs from human donors, as well as in a population of dendritic cells enriched in autoimmune regulator (AIRE)+ cells and identified as HLA-DRhigh CD45low. Results The relative frequency of different LNSC subsets was altered in both donors with type 1 diabetes and NOD mice, and both MHC class II and programmed death-ligand 1 (PD-L1) expression were upregulated in human type 1 diabetes. Tolerance-related genes showed similar expression profiles between mouse and human LNSCs at steady state but were generally upregulated in the context of human type 1 diabetes, while, at the same time, many such genes were downregulated in the AIRE-enriched dendritic cell population. Conclusion/interpretation Our study shows that LNSCs are substantially altered in type 1 diabetes, but, surprisingly, they exhibit an enhanced tolerogenic phenotype along with increased antigen-presenting potential, which may indicate an attempt to offset dendritic cell-related tolerogenic defects in tolerance. Thus, LNSCs could constitute alternative therapeutic targets in which to deliver antigens to help re-establish tolerance and prevent or treat type 1 diabetes. Data availability All data generated or analysed during this study are included in the published article (and its online supplementary files). Biomark gene expression data were deposited on the Mendeley repository at https://data.mendeley.com/datasets/d9rdzdmvyf/1. Any other raw datasets are available from the corresponding author on reasonable request. No applicable resources were generated or analysed during the current study.Keywords
This publication has 37 references indexed in Scilit:
- Transcriptional profiling of stroma from inflamed and resting lymph nodes defines immunological hallmarksNature Immunology, 2012
- Positive and negative regulation of T cell responses by fibroblastic reticular cells within paracortical regions of lymph nodesFrontiers in Immunology, 2012
- Expansion of Th17 Cells and Functional Defects in T Regulatory Cells Are Key Features of the Pancreatic Lymph Nodes in Patients With Type 1 DiabetesDiabetes, 2011
- Control of central and peripheral tolerance by AireImmunological Reviews, 2011
- Lymph node stroma broaden the peripheral tolerance paradigmTrends in Immunology, 2011
- Lymph node fibroblastic reticular cells directly present peripheral tissue antigen under steady-state and inflammatory conditionsJournal of Experimental Medicine, 2010
- Lymph node–resident lymphatic endothelial cells mediate peripheral tolerance via Aire-independent direct antigen presentationJournal of Experimental Medicine, 2010
- Deaf1 isoforms control the expression of genes encoding peripheral tissue antigens in the pancreatic lymph nodes during type 1 diabetesNature Immunology, 2009
- Deletional Tolerance Mediated by Extrathymic Aire-Expressing CellsScience, 2008
- Pancreatic Lymph Nodes Are Required for Priming of β Cell Reactive T Cells in NOD MiceJournal of Experimental Medicine, 2002